If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 101 - 110 of 294
Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation (PREDICT-RT*)
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial
Protocol No
NRG-GU009-PREDICT-RT
Categories
SAkuraPEAK: A Phase 1, Multicenter, Open-Label, Uncontrolled Study to Evaluate Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Satralizumab in Adult Patients with AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder with Body
Satralizumab in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder
Protocol No
NEURO-GENENTECH-SAKURAPEAK
A Phase 1 Multicenter Dose Escalation and Dose Expansion Study of Antibody-Drug Conjugate MYTX-011 in Subjects with Non-Small Cell Lung Cancer
A Phase 1 Study of MYTX-011 in Subjects with NSCLC
Protocol No
MYTHIC-MYTX-011-01
Categories
A Phase 1, First-in-human (FIH), Dose-finding and Expansion Study to Evaluate the Safety and Tolerability of XmAb808 in Combination with Pembrolizumab in Selected Advanced Solid Tumors
A Phase 1 Study of XmAb808 in Select Advanced Solid Tumors
Protocol No
XENCOR-XMAB808-01
Categories
Cancer,
Colorectal,
Early Phase/Multiple Disease Site Cancers,
Thoracic Cancers,
Skin Cancers,
Prostate and Urologic Cancers,
Head and Neck Cancers,
Gynecologic Cancers,
Gastrointestinal Cancers,
Breast Cancers,
Lung,
Melanoma, Skin,
Bladder,
Prostate,
Kidney,
Lip, Oral Cavity and Pharynx,
Larynx,
Ovary
TES To Remediate Phonological Impairments After Stroke
TES for Language Impairment
Protocol No
NEURO-IIT-SHAH-TES
Categories
Examination of Motor Unit Alterations in Acute and Subacute Stroke
Motor Unit Alterations in Acute and Subacute Stroke
Protocol No
NEURO-IIT-LI-MOTOR-UNIT-ALT
Categories
A Randomized Clinical Trial of tDCS to Remediate Phonological Impairment in Aphasia
HD-tDCS for Phonological Impairment in Aphasia
Protocol No
NEURO-IIT-PILLAY-ALF-TDCS
Parkinson's Foundation PD GENEration Genetic Registry
Parkinson's Foundation PD GENEration Genetic Registry
Protocol No
NEURO-PF-PDGENE
A Phase 1, Open-Label, Multicenter, Dose Escalation Study of SGR-1505 as Monotherapy in Patients with Mature B-Cell Malignancies
A Phase 1 Study if SGR-1505 in Patients with B-Cell Malignancies
Protocol No
SCHRODINGER-SGR-1505-101
Categories
A Randomized, Double-Blind, Placebo-Controlled Trial of IkT-148009 in Untreated Parkinson's Disease
IkT-148009 in Untreated Parkinson's Disease
Protocol No
NEURO-INHIBIKASE-IKT-148009